Contact an attorney who focuses on healthcare regulatory law and FDA compliance
As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients
Paracetamol (5001000 mg every 46 hours, maximum 4 g daily) represents a safe first-line option for most patients
The clinics innovative culinary medicine program takes nutritional counseling a step further by offering hands-on cooking classes and workshops that teach patients how to prepare healthy, flavorful meals at home building lifelong skills that support lasting dietary change
In less common cases, semaglutide may be linked to more serious side effects
A BMI of 30 is considered obese